Company profile: ScandiDos
1.1 - Company Overview
Company description
- Provider of a unique measurement system for radiation therapy in cancer treatment.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ScandiDos
Lindis Blood Care
HQ: Germany
Website
- Description: Provider of a medical device for removing cancer cells from intraoperative blood during cancer surgeries to enable autologous blood transfusion (CATUVAB), and a multicenter clinical certification study (REMOVE) assessing the device’s efficacy and safety in tumor cell removal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindis Blood Care company profile →
Myelo Therapeutics
HQ: Germany
Website
- Description: Provider of treatments addressing high unmet medical needs, focused on developing myelo001, a small molecule effective on hematogenesis and investigated for its oral application in treating chemotherapy-induced myelosuppression, radiation-induced myelosuppression, and acute radiation syndrome. Founded in 2013 and based in Berlin, Germany.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myelo Therapeutics company profile →
Traws Pharma
HQ: United States
Website
- Description: Provider of clinical-stage small molecule oral therapies, including investigational inhibitors for COVID-19 (TRX01/ratutrelvir) and pandemic influenza (TRX100/tivoxavir marboxil), and narazaciclib, a proprietary multi-kinase CDK4-plus inhibitor in trials for refractory endometrial and metastatic breast cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Traws Pharma company profile →
Seagen
HQ: United States
Website
- Description: Provider of monoclonal antibody-based therapies and advanced antibody-drug conjugate technology focused on improving patient outcomes in cancer and autoimmune diseases. Lead program SGN-35 is in a pivotal trial for patients with relapsed or refractory Hodgkin lymphoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seagen company profile →
ClearNote Health
HQ: United States
Website
- Description: Provider of cancer detection solutions, including the Avantect Pancreatic Cancer Test—a blood test that detects pancreatic cancer in its earliest stages by measuring the biomarker 5hmC; the Virtuoso Epigenomics Platform—a whole genome sequencing and 5hmC enrichment solution for revealing active disease biology for drug discovery and development; and targeted multi-cancer panels that track epigenomic signals via a single blood draw.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClearNote Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ScandiDos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ScandiDos
2.2 - Growth funds investing in similar companies to ScandiDos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ScandiDos
4.2 - Public trading comparable groups for ScandiDos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →